Menu
OR
OR
Novel Drug Targets for Osteoarthritis Through Integrative Blood-Based Omics

Orthopedic Surgery - Orthopedic Rehabilitation

This infographic highlights a recent study that identified novel and effective drug targets for osteoarthritis (OA) by leveraging integrative blood-based omics. Using proteome-wide association studies (PWAS), Mendelian randomization, and replication analysis, researchers found seven proteins linked to OA risk, including ECM1 and PCSK1. The findings offer promising therapeutic targets for future drug development by uncovering protein-related genetic risk factors for knee and hip OA.


0 Likes

0 Comments


Profile
Orthopedia Insights

Welcome to Orthopedia Insights, an educational platform designed for orthopedic specialists seeking the latest in medical advancements and treatment innovations. Through concise, two-minute video breakdowns of the most relevant published research and impactful infographics, we simplify complex medical information into easily digestible insights. Explore the evolving landscape of orthopedics, from innovative surgical techniques to advanced pain management strategies, and stay updated with the latest developments in the field.

© 2024 Imedsource, All Rights Reserved

Sustain the Knowledge Stream!

For unrestricted access to content and a seamless experience,

Continue to Login

Don't have an account?

We’d love to get to know you better!

Complete your profile to help us deliver a more personalized experience.